The term spindle-cell sarcoma should not be used to describe a tumour entity as by "using such a term the reporter confesses his inability to recognize the nature of the tumour". The author also condemns the use of the term "neurogenic sarcoma" to describe a soft tissue sarcoma unless it is derived from peripheral nerves. The 9 cases of neurogenic sarcoma in the author's list had no definite diagnostic features in the sections except for the arrangement of fibres in "whorls". Again the term myxosarcoma is misleading as such a tumour, chiefly composed of fibroblasts with areas of mucoid degeneration, is not a definite clinical entity.
The greatest incidence is between 20 and 30 years of age, but they may occur in infants a few weeks old, in whom fortunately the prognosis is not always hopeless.
The sex incidence shows a preponderance in men for tumours of trunk and limbs. In other sites the sex incidence is equal. The site incidence shows that the majority occur in the limbs, the lower limb being the commonest site of all. Prognosis is most favourable for tumours in limbs and trunk. JAN.-SURG. i Proceedings of the Royal Society qf Medicine 2 Fibrosarcoma (the commonest type) is derived from fibroblasts. It is composed of spindle cells with an elongated nucleus. Metastases are multiple and widespread. Synovial sarcoma has a distinct histology. It occurs in connexion with burse, tendon sheaths or joints. Its prognosis is worse than that of fibrosarcoma.
Liposarcoma is rare. Main features are foamy embryonal fat cells, rapidity of growth and great size.
Rhabdomyosarcoma may be of two varieties-cells with longitudinal and cross striation, and broad ribbon cells.
Angiosarcoma is markedly vascular. Three main methods of treatment were used (1) Wide excision in association with radiotherapy, both pre-and post-operative; (2) Amputation, alone or with radiation;
(3) Radiation only. Local excision by enucleation proved to be a failure owing to recurrence. Knowledge of the histological type is important for prognosis. Amputation is not a "cure". Neither should radiation alone be advised where wide excision is possible.
In this series survival up to 26 years has been obtained and half the patients have been salvaged.
The author suggests that radiation in moderate doses over long periods breaks the chromosomes, thus causing gene mutations and in time the cells become non-reproductive. Sublethal radiation may also produce chemical intracellular changes resulting in sterility of the malignant cells.
The author's results showed a longer survival after conservative excision and radiation than after amputation.
RtSUMm. -Discussion sur une serie de 153 cas de sarcome des parties molles, la plus longue proverlant d'une seule source rapportee jusqu'ici. La rarete des tumeurs de ce genre, le manque de precision de la nomenclature et les resultats decevants du traitement sont demontres par des allusions 'a la litterature. Parmi ces 153 cas il n'y en a que 7 oiu le diagnostic n'a pas ete prouve par l'examen histologique. I1 existe des sections ou des rapports histologiques pour 146 cas. 148 malades ont ete suivis jusqu'a present ou jusqu'a leur deces. L'auteur definit le sarcome des parties molles comme une tumeur d'origine mesenchymale, se produisant en rapport avec le tissu conjonctif des aponevroses, des gaines tendineuses, des cloisons intermusculaires et des membranes synoviales. Leur Le terme "sarcome fuso-cellulaire" ne devrait pas etre employe pour decrire une entite tumorale, car "par l'emploi d'un tel terme l'auteur s'avoue incapable de reconnaitre la nature de la tumeur". L'auteur condamne aussi l'emploi du terme "sarcome neurog'ene" comme description d'une tumeur des parties molles a moins qu'elle provienne d'un nerf periph6rique. Dans les 9 cas de sarcome neurogene dans la liste de l'auteur le seul caract6re diagnostic defini est l'arrangement des fibres en "spirales". De plus, le terme myxosarcome est trompeur, car une tumeur de cette espece, composee principalement de fibroblastes avec des plages de degenerescence mucoide, n'est pas une entite clinique bien determinee.
L'incidence maximum de ces tumeurs est entre les ages de 20 et 30 ans, mais elles peuvent survenir chez des enfants de quelques semaines, chez lesquels le pronostic n'est heureusement pas toujours fatal.
L'incidence d'apres le sexe montre que les tumeurs du tronc et des membres sont plus frequentes chez les hommes. Pour les autres situations la frequence est la meme chez les deux sexes. Le pronostic est le plus favorable dans les tumeurs des membres et du tronc.
Le fibro-sarcome (le type le plus frequent) provient des fibroblastes. II consiste en cellules fusiformes a noyau allonge. Les metastases sont multiples et largement repandues. Le sarcome synovial a une histologie speciale. I1 survient en relation avec les bourses synoviales, les gaines des tendons ou les articulations. Le pronostic est moins favorable que celui des fibro-sarcomes.
Le liposarcome est rare. Ses principaux caracteres sont des cellules graisseuses embryonnaires ecumeuses, une croissance rapide et un grand volume.
Le sarcome rhabdomyoblastique peut prendre deux formes, l'une 'a cellules striees en longueur et en largeur, et l'autre 'a cellules larges en ruban.
L'angiosarcome presente une vascularisation prononcee. Pour le traitement, trois methodes principales ont ete employees: (1) l'excision large avec radiotherapie preet post-operatoire, (2) l'amputation, seule ou avec radiotherapie, (3) la radiotherapie seule. L'excision locale par enucleation s'est montree inefficace 'a cause de recidives. Ii est important de connaitre le type de la tumeur pour determiner le pronostic. L'amputation n'assure pas la guerison. La radiotherapie seule n'est pas non plus 'a recommander si l'excision large est possible.
Dans cette serie de cas des survies de jusqu'a 26 ans ont ete obtenues, et la moitie des malades ont ete sauves.
L'auteur suggere que l'irradiation prolongee peu intense et it doses moderees detruit les chremosomes, produisant par ce fait une mutation des genes, et qu'avec le temps les cellules perdent le pouvoir de se reproduire. L'irradiation sous-lethale peut aussi produire des changements chimiques intra-cellulaires aboutissant 'a la sterilite des cellules malignes.
Les resultats obtenus par l'auteur montrent une plus longue survie apres l'excision large avec radiotherapie qu'apres l'amputation.
RESUMEN.-Se discute una serie de 153 pacientes, la mayor hasta ahora registrada procedente de una unica fuente, afectos de sarcoma de tejidos blandos. Las referencias en la literatura muestran la rareza de estos tumores, la falta de claridad en la nomenclatura y los desilusionantes resultados del tratamiento. De los 153 pacientes, solamente en siete casos faltaba una confirmacion histologica del diagnostico. En 146 casos se dispone de preparaciones e informes histologicos. 148 pacientes han sido observados hasta su muerte o hasta la fecha. El autor define el sarcoma de los tejidos blandos como un tumor, de origen mesenquimatoso, que aparece en asociacion con el tejido conjuntivo de fascias, aponeurosis, vainas tendinosas, septos intermusculares, musculatura esqueletica y membranas sinoviales. Histologicamente se clasifican como: 
11
Sin diagn6stico histol6gico .. ..
7
El termino "sarcoma fusocelular" no debe usarse para describir una entidad tumoral 'como si usando tal terminologia confesase el observador su incapacidad para averiguar la naturaleza del tumor". El autor condena, asimismo, el uso del termino "sarcoma neurogenico" para describir un sarcoma de tejido blando, a no ser que este haya derivado de los nervios perifericos. Los nueve casos de sarcoma neurogenico en los protocolos del autor, tienen como unica caracteristica diagnostica definida la disposicion de sus fibras en "torbellinos". El termino "mixosarcoma" es igualmente equivoco, puesto que tal tumor, compuesto principalmente de fibroblastos con areas de degeneracion mucoide, no es una entidad clinica definida. La mayor incidencia de estos tumores ocurre entre los 20 y 30 anos de edad, aunque tambien pueden aparecer en ninios de pocas semanas, en los que el pronostico, afortunadamente, no es siempre desesperado.
En el varon estos tumores se localizan, preponderantemente, en el tronco y las extremidades. La incidencia de los que se localizan en otras regiones es igual en ambos sexos. En general, la mayoria de ellos se desarrollan en las extremidades, siendo las piernas su localizacion mms frecuente. El pronostico es ma s favorable en los tumores de las extremidades y tronco. El fibrosarcoma (el tipo ma's comuun) deriva de los fibroblastos. Estaa formado por celulas fusiformes, con nucleo alargado. Las metastasis son muiltiples y diseminadas. El sarcoma sinovial tiene una histologia tipica; aparece en las bolsas sinoviales y vainas tendinosas o articulares. Su pronostico es peor que el del fibrosarcoma.
El liposarcoma es raro; sus principales caracteristicas son: ce'lulas adiposas embrionarias, de aspecto espumoso, rapidez de crecimiento y gran tamanio. El rabdomiosarcoma puede ser de dos tipos-celulas con estriaci6n longitudinal y cruzada, el uno, y anchas celulas en forma de cinta, en el otro-.
El angiosarcoma es marcadamente vascular. Los tres metodos de tratamiento principalmente usados son: (1) Amplia ablaci6n asociada a radioterapia, pre y postoperatoria; (2) Amputacion, unida o no a radioterapia; (3) Radioterapia unicamente. La extirpaci6n local, por enucleacio n, no ha dado resultado debido a las recidivas. El conocimiento del tipohistologico es de importancia para el pronostico. La amputacion no es una cura, como tampoco lo es la radioterapia, recomendable solamente cuando una amplia extirpacion es posible.
En la serie estudiada se han conseguido supervivencias hasta de 26 anios, habiendo sido salvados la mitad de los pacientes.
El autor sugiere que la radioterapia en dosis moderadas durante largos periodos rompe los cromosomas, causando de esta manera la mutacion de los genes, y al cabo del tiempo las celulas pierden su capacidad reproductora. Una irradiaci6n subletal puede producir tambien cambios quimicos intracelulares que determinan la esterilidad de lascelulas malignas.
Los resultados del autor muestran una mayor sobrevivencia despues de una extirpacion conservadora unida a radioterapia que despues de la amputacion.
It has been my good fortune to have had under my care or the joint care with one or other of my colleagues a series of 153 patients suffering from soft tissue sarcoma. The rarity of such tumours can be judged from the literature. The largest series I have been able to find are those of Gunnar Jonsson (1938) , 92 collected cases (from Sweden); Moulonguet and Pollosson (1938), 119 cases (from France); Warren and Sommer (1936) , 150 cases; and Nathanson and Welch (1937) , 161 collected cases (in theUJnited States). Personal series are very much smaller; even the surgical giant Gordon-Taylor (1940) could muster only 20 personal cases and 9 others seen by him in consultation up to 1938, and he records that at that time there were in all only 43 other cases at the Middlesex Hospital. My series of 153 patients seems therefore the largest personal number and forms an important group for careful study; it covers a period of thirty years. However, what prompted me to choose "Soft Tissue Sarcoma" as the subject of this Presidential Address is the completeness of the records. Of the 153 patients, only 7 have no histological confirmation of the diagnosis; in 146, sections and histological reports by one or more pathologists are available. Further, only 5 patients are untraced, whereas 148 have been followed up either to death or to date. Because of their rarity, their complexity of structure and their unpredictable clinical behaviour as compared to the more common types of cancer, the personal experience of most surgeons in this type of tumour is very limited and this limitation is reflected in the literature which usually deals with small groups of cases, in the nomenclature which seems untidy and at the mercy of passing fashions and in the methods of treatment which by their disappointing results have given these tumours a sombre reputation and a gloomy prognosis.
It seemed to me that this series offered an opportunity to assess the present state of our knowledge. The review of the material in the light of experience justifies a reorientation of the clinical ideas, a need for a simplification of the nomenclature and a change in the usual practice as regards treatment.
NOMENCLATURE AND CLASSIFICATION
By soft tissue sarcoma is meant a tumour of mesenchymal origin arising in association with the connective tissue of the fascia aponeurosis, tendon sheaths, intermuscular septa, voluntary muscles and synovial membrane. It is ofcourse known that similar types oftumour do occur in other sites: the skin, the breast, the mesentery, the gut, the omentum, even the brain; but this study is not concerned with these sites. The histological structure of these tumours varies and in my series the following names were used in the pathological reports. The heading "various" in Table I included "angioendothelioma", "angiosarcoma", "perithelioma", "hemangioendothelioma" and compound names of any two or more, such as "lipo-myxosarcoma", &c., and some others as bizarre and obscure as the histological picture itself.
It is of course open to the pathologist to use any one of these names; it should be equally open to the clinician to reject some of them as of little value in practice. The histologist can label the tumour by a dlescriptive term, such as the shape of the most common cell of the tumour; or base his nomenclature on the genesis of the cell. Descriptive and histogenetic terms are sometimes complementary.
The commonest term used is "spindle-cell sarcoma". I suggest that this term, although accurate descriptively, is valueless from the clinical point of view and should not be used to indicate a tumour entity. There are other tumours composed of spindle cells with marked pleomorphism such as osteogenic sarcoma, where this term is not used as an identification mark; yet others, not derived from mesenchyme, such as tumours of neuro-ectodermal origin, which are composed of spindle cells. Stout (1948) , the most experienced tumour histologist in the United States does not hesitate to say that by using the term "spindle-cell sarcoma" the reporter confesses his inability to recognize the nature of the tumour.
Neither am I alone in rejecting the term "neurogenic sarcoma" commonly used for the histological identification of soft tissue sarcoma. I am fully aware that this term represents the concept of no less a pathologist than James Ewing himself; that it was supported and popularized by Quick and Cutler (1927), Stewart and Copeland (1931) , that it emanated from the Memorial Hospital; that it was accepted by all and sundry; has found its way into textbooks and monographs; has enjoyed a popularity quite undeserved for twenty-five years, although now somewhat on the wane. I reject it nevertheless and I do so in company of Gunnar Jbnsson (1938) of the Radiumhemmet who states "the author has not adopted the theory of neurogenic origin", and again with Stout (1948) who says: "Thus since the term (neurogenic sarcoma) is a chimera, it will serve only as a bar to progress as long as it continues to be used." It is also significant that in the Panel Discussion on "Soft Part Tumours" at the National Cancer Conference in Memphis, Tennessee, in 1949, it was recorded that "after a recent review of several hundred tumours previously classified at the Memorial Hospital as neurogenic sarcoma, most of the tumours were removed from this category and the remaining are now designated 'schwannoma' ". It is, of course, obvious that neurogenic sarcomas exist, but there must be some evidence that they are derived from peripheral nerves, and there should be more definite criteria by which they can be recognized. It is, besides, unreasonable to accept the theory that most tumours originating in fascia, aponeurosis, tendon sheaths, perimesium, intermuscular septa, should, in fact, not arise from these structures at all, but from the nerves in their vicinity. As a clinician, I am of course not concerned primarily with the actual "label" of a tumour but with the significance of such a label in relation to the prognosis and to the choice of treatment. The 9 cases labelled neurogenic sarcoma in this series, now included in the fibrosarcoma group, were therefore very carefully reviewed. The following points were noted: In all 9 cases the tumour was composed of spindle cells, indistinguishable under high power from the spindle cells in other sarcoma. In all 9 cases there was a distinct arrangement described as "whorled" or "pallisade". This arrangement (Fig. iB) is shown in several monographs as an illustration of a fibrosarcoma and attention is drawn to the fact that the bundle of cells and fibres bend sharply and at right angles when they meet. The 9 cases were submitted to various pathologists and the same section on several occasions was variously reported as "sarcoma", "neurinoma", "neurogenic sarcoma", "neurofibroma", "fibrosarcoma", or even "myxosarcoma". Except for the whorled arrangement (Fig. 1B ) of fibres there seems to be no definite diagnostic feature in the sections. On the clinical side, the tumours were situated in close proximity to muscles, or intermuscular spaces in the following sites: vastus medialis, sartorius, tensor fascie femoris, quadriceps, Scarpa's triangle, biceps, triceps, scalene muscles. All the cases received Proceedings of the Royal Society of Medicine 6 much the same treatment as other patients labelled "fibrosarcoma". Of the 9 patients, 4 died with metastases, chiefly in the lungs, in periods up to two years; 5 are alive for periods of ten, nine, four, four, and two years, and 2 of these are alive with disease. Clinically there is no difference between these patients and the majority of the fibrosarcoma group. They are neither more nor less malignant;-survival of ten and nine years has been achieved in some and in others death from metastasis noted. The descriptive term "spindlecell sarcoma" even when adumbrated by the prefix "large" or "small" and joined to the term "neurogenic" does nothing to clarify our knowledge of the tumour.
To my list of negations I will add one more: "myxosarcoma". Whereas a "myxoma" is a true neoplasm, "composed of stellate cells set in a loose mucoid stroma through which course very delicate reticulum fibres" (Purdy Stout, 1948) , a tumour which does not metastasize and occurs commonly in the heart (110 recorded cases), the skin and elsewhere; the so-called "myxosarcoma" is, in fact, a tumour chiefly composed of fibroblasts, showing areas of mucoid degeneration (Fig. Ic) . It is not a specific clinical entity. As Willis-(1948) points out: "There is no such cell as a 'myxoblast' distinct from the 'fibroblast'." But even with the rejection of these various terms from the nomenclature of soft tissue tumours, there remains quite a list of different varieties. 
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Before considering in some detail the main features concerning the structure and behaviour of each subgroup it is convenient to summarize briefly some factors applicable to the whole group.
AGE AND SEX INCIDENCE
No age is immune. These tumours occur from birth to old age; the greatest incidence is between 20 and 30 years, but each decade between 10 and 50 years is also represented. Attention must be drawn to the occurrence of these tumours in infants a few weeks or months old and it is important to point out that the prognosis in these very young patients is not always as hopeless as it is believed to be and that they are amenable to treatment and some survive to adult life without recurrence.
The sex incidence shows a preponderance in men; of the total 153 patients, 86 were male and 67 female. It is interesting to note that this preponderance in men applies only to the tumours in the trunk and limbs, whereas in "odd" sites, head and neck, retroperitoneal and in multiple tumours, the sex incidence is equal.
SITE INCIDENCE OF SOFT TISSUE TUMOURS
The majority of soft tissue tumours occur in the limbs. Table IV shows the site incidence. Over half of the total were found in the lower limb, a quarter in the upper limb; 11 % in the trunk, head and neck and a similar number in miscellaneous sites, such as the palate, orbit, &c. ! L . Various points of interest emerge from an analysis of the site incidence. Thus the survival rates are far fewer in the "odd" sites and the length of survival far shorter than in the limbs, trunk and head and neck. Of 135 cases with such tumours 63 died of the disease; but of these one-third lived more than five years (five to twenty-two years) and under half of the total of deaths occurred in less than two years. The outlook in the "odd" sites is far worse; thus 14 of 18 cases died; half in the first year and the other half in the second year. Thus 80% of soft tissue sarcoma in odd sites caused death within two years from the onset of the disease.
A more detailed study of the site incidence is of practical interest as it affects the actual operative treatment. It is convenient, whenever possible, to localize the tumour to the muscle or muscle group where it is situated; it should be understood that it is not meant that the tumour is actually localized to the muscle in question and lies within it, although this does occur in a proportion of cases; in most it is the connective tissue around the muscle or between muscle groups which at first harbours the tumour. Eventually, it penetrates, invades or spreads along muscle planes. Thus the anatomical names of muscles should be taken as referring to a region. With this understanding the site incidence can be broken down as follows:
Lower limb.-This is the commonest site of all (Fig. 2, B , C, D, E); 80 patients or 52 3 % of the total developed a tumour in the lower limb. Of these the quadriceps extensor group accounted for 16 cases, of which 6 were actually in the vastus medialis. Next in frequency were the glutei muscles and the gastrocnemius group, 11 cases in each. The details of the remaining sites are shown in Table V . In the early stages of the disease, it is possible to excise a section of the musculature including the tumour and a good, adequate surrounding margin without damage to the main blood supply of the limb and often with a good functional result. This is specially applicable to tumours of the buttock, where after preliminary ligation of the internal iliac artery, the three glutei can be excised very nearly in toto; the gastrocnemius, vastus medialis, the sartorius and tensor fascia femoris can also be dealt with that way with surprisingly little subsequent functional disability.
In the upper limb the incidence of tumours is 25% of the total, that is less than half of the incidence in the lower limb. The distribution of the tumour is more limited and is shown in Table VI . The main sites account for about an equal number of cases: pectoral group, scapular muscles, deltoid, the extensors or flexors of the arm or forearm. Here too, provided opportunities are not missed and a planned treatment undertaken the first time, an entire group of muscles and, in the case of the scapular group, the scapula itself can be removed and so a wide excision achieved.
The remainder site incidence accounts for a small number in the trunk and in the muscular and aponeurotic tissue of the head and neck.
Abdominal wall .. Back (erector spina) (1) Fibrosarcoma (Fig. 1) .-This is the commonest type of tumour. It is derived from fibroblasts and is composed of spindle cells with an elongated nucleus. The function of the fibroblast is to form connective tissue, the collagen fibres. The tumours vary in degree of differentiation and anaplasia, mitotic incidence, arrangement of fibres, size of cells, amount of intercellular stroma (Fig. 1, A, B, C) . ThUs there is a considerable variation in the sections, some resembling adult fibrous tissue, others embryonic cells and some showing considerable pleomorphism, with increased vascular supply and occasional giant cells.
It is suggested that these variations do not justify classifications into various entities under different names, but should be grouped like epithelial tumours into grades of malignancy from the least to the most differentiated. The collagen material can undergo degeneration and give the appearance of structureless areas, the so-called myxomatous degeneration.
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The tumours are all invasive, and invasion of fat, muscle and bone is seen. The gross appearance of these tumours is of interest. In the early stages they are rounded, encapsulated, smooth, firm, pink or yellow on section. Their invasive characters are not apparent to the naked eye, except when small satellite nodules are seen. At a later stage, when the tumours are considerable in size, they become elongated as if moulded by the surrounding muscular masses or multilobulated. But even then they seem for a time to respect the adjoining tissues especially blood vessels and nerves. The capsule is still found in the larger tumour, although thin and incomplete; it is no barrier to the spread of the tumour and affords no protection against it. It is misplaced faith in the capsule which permits easy enucleation of the tumour, which is responsible for so much inadequate surgery; inadequate in the sense that it seldom if ever leads to an eradication of the tumour and is invariably followed by local recurrence. The skin over the tumour remains normal for a long time, showing only some venous .engorgement (Fig. 2D ). Unlike bone sarcoma, local vascularity is not increased; the tumour feeds on one or two isolated vessels at the periphery and from attenuated, insignificant capsular vessels.
In the late stages the tumour breaks down and cystic areas appear, containing blood or serum or myxomatous or collagenous material (Fig. 2c) . The tumour is painless, it grows slowly and a history of two or three years is common; although in some cases the growth is more rapid. It is also noted that periods of obvious increase in size are often followed by periods of quiescence. In a proportion of cases a definite history of injury at the site of the tumour is obtained. The occurrence of fibrosarcoma as a sequela to old war wounds is well known. Post-radiation scarring too, leads to this type of tumour, although far less commonly than to post-radiation epithelial cancer. This relation between trauma, scarring and fibrosarcoma is now usually accepted; the time interval between the injury and the formation of the tumour varies from a few months to many years. The longest interval recorded is the following case reported by Purdy Stout (1948) .
This patient injured his back as a child; at the age of 9 he developed a lump in the scar; at the age of 35, because of rapid recent increase in size, it was excised in London by Lord Lister. The tumour recurred, again grew slowly for years, then more rapidly and at the age of 65 it was again excised, this time at the Presbyterian Hospital, New York. There was no recurrence after that for a further twenty-five years when he was seen by Whipple. The patient was then 91 years of age and a period of eighty-two years had elapsed since the onset of fibrosarcoma.
FiG. 3.-Pulmonary metastases from a fibrosarcoma of soft tissue. The variation in size of the metastases indicates that there were repeated embolic deposits throughout a period of several months.
Local recurrence after enucleation is so common as to be the rule ( Fig. 2A) . In my series several patients submitted to operation six or more times in periods varying from two to fifteen years.
Metastases: Metastases occur chiefly in the lungs but also in the skeleton, lymph glands, liver and in some patients as a terminal phenomenon they are multiple and widespread. There may be a time lag of several years, the longest in my series was eight years, before pulmonary metastasis developed in the absence of any local recurrence. The pulmonary metastases are usually multiple, circumscribed, round shadows, small at first but rapidly becoming the well-known cannon-ball type (Fig. 3) . Although both primary tumour and metastases are radioresistant, this is no contra-indication to radiotherapy.
Of the 112 histologically verified fibrosarcomata, 101 occurred in the limbs and trunk; of these 53 are alive and 48 dead; of the 11 cases in odd sites, 8 are dead and only 3 alive.
(2) Synovial sarcoma.-The name "Synovioma" was first suggested by Lawrence W. Smith in 1927, but several reports on malignant tumours arising from synovial structures are found in the literature prior to that date (Marsh, 1898; and Lockwood, 1902) . Other names "synovialoma", "malignant synovioma", "synovial fibrosarcoma" are used for this tumour. Synovial sarcoma seems the most suitable term and preferable to "synovioma", as the latter may be confused with benign lesions of similar structure.
The distinction between these malignant tumours and others pursuing a benign course was recognized early in this century. These benign lesions, some of them probably inflammatory swellings were described as xanthomata or benign synovioma. Haagensen and Stout (1944) point out that these tumours but seldom arise actually from joint spaces. It is of course well known that they may arise from burse and tendon-sheaths. Most authors distinguish two varieties differing in their histological structure. The one showing the characteristics of the tumour, namely tissue resembling, mimicking or caricaturing synovial tissue-slits and spaces lined by cuboidal or even columnar-shaped cells; the other consisting of solid masses of elongated plump spindle cells with considerable vascular spaces (Fig. 4A ).
There is a great variation in the amount of fibrosarcomatous elements. Haagensen and Stout's conception of the tumour-that it is "always composed of two sharply contrasted tissue forms, one reproducing caricatures of synovial structures, the other resembling fibrosarcoma and the two are inextricably intermingled" (1944)-is preferable to the subdivision into two different types under the names of "synovialoma" and "synovial fibrosarcoma", both malignant as suggested by Gunnar Jonsson (1938) . There is in fact only one type and variations are only in the degree of differentiation and degeneration. If the diagnosis is to be made with confidence many sections should be. examined. The histology is so distinct as to suggest that this is a definite tumour entity. This is supported by the clinical features and by the behaviour of the tumour.
The tumours occur most often in connexion with bursae, tendon sheaths or joints. The history in most cases is of one or two years, but hardly ever longer; in a minority it is of a few months only. The tumour causes slight pain or discomfort but seldom severe pain. If not removed it may grow to a large size-soften and develop cystic spaces filled with blood or serum or jelly-like material. In the 11 patients in my series the sites were: subacromial bursa (delto-pectoral area) 3; elbow-joint 2; hand 2; knee 1; tendo achillis 1 ; calf of leg 1; gluteal region 1. Of these 11 patients 4 are dead; 2 alive with disease and 5 free from disease, 1 for five years, 1 for four yeakrs, and 3 under three years. The cause of death was metastases in muscles and viscera, including lungs. Of the 104 cases collected by Haagenson and Stout only 3 are known to be free from disease more than five years. Of 32 cases at the Army Institute of Pathology, Washington, 16 were known to have died at the time of reporting but the follow up was at that time incomplete.
Synovial sarcoma is of worse prognosis than fibrosarcoma; they are rare tumours; they show distinct histological features; they cause discomfort but generally slight pain only; they destroy adjoining bone like the fibrosarcomata; they often show small areas of calcifications; they kill within two to four years, chiefly by metastasis; they are radioresistant.
(3) Liposarcoma.-This rare tumour is represented six times in this series, an incidence of 4%. In a period of thirty-seven years there were only 41 cases at the Columbia University Laboratory of surgical pathology (A. P. Stout, 1944) . Although rare it is a definite entity and presents many interesting points. The characteristic histological feature is the presence of foamy embryonal fat cells (Fig. 4B) ; this intracellular fat is easily demonstrated in frozen sections and by special staining methods. There are many areas of myxomatous degeneration, and many spindle cells, and so various names are applied to this tumour. "Myxolipoma", "myxoliposarcoma", "fibromyxolipoma", "embryonic lipoma". Well-differentiated and poorly differentiated myxoid types are described and round-celled tumours of the adenoid type. Some tumours which recur locally and form many satellite masses in the vicinity, invade muscle extensively and even bone, and eventually metastasize, show the histology of a benign lipoma. The macroscopical appearances are also varied; the tumours are bulky and in fact they are the largest soft tissue tumours and may attain an enormous size (Fig. 2D) . Their colour is salmon pink, bright yellow, or reddish brown and has been described as the colour of wet chamois leather. They are multilobulated, partially encapsulated, soft with areas ofcystic degeneration; the cysts containing fresh or altered blood. They spread interor intramuscularly; clinically they are found chiefly in the buttock and thigh;
next in frequency are the retroperitoneal or perirenal areas, and occasionally on the upper limb or other sites. They grow rapidly, but show spontaneous periods of growth arrest, an intermittency which is also seen in other varieties of soft tissue sarcomas. Occasionally a liposarcoma occurs as a metaplasia in a pre-existing lipoma, but the majority are malignant ab initio. Metastases occur in the lungs and liver; the age incidence is the 5th and 6th decades, but occasionally the tumour occurs in the younger age-groups; one of my patients was a soldier 19 years of age. Surprisingly, they have been reported as radiosensitive, but I have no personal experience of this. They can grow to an enormous size ( Fig. 2D ) and A. P. Stout (1944) illustrates a patient reported by Delamater in 1859 where the tumour reached 275 lb. In one of.my patients the tumour measured 41 cm. in length and 16 cm. across, and had reached that size in five months.
The main features of this variety are: foamy embryonal fat cells, rapidity of growth, great size; the usual site is the thigh, buttock or retroperitoneal space; the spread along muscle planes and the invasion of muscles; the formation of metastases in soft tissues, including liver and lung. Of the 6 cases, 3 died within eight to twenty months and 3 are alive, the longest only three years.
(4) Rhabdomyosarcoma.-Two varieties of cells characterize this tumour; cells with longitudinal and cross striation (Fig. 4c ) and broad ribbon-shaped cells with a granular vacuolated cytoplasm, with occasionally part of it striated, the myoblast. Either one or both types of cells can be found in the same tumour. The distinction of two varieties of tumour: the rhabdomyosarcoma and the myoblastoma is hardly justified as careful search of a number of sections nearly always shows both types of cells in the same tumour. Clinically it is the most malignant of all soft tissue tumours and of the 7 cases in my series none survived. 2 occurred in the upper limb and in spite of amputation both died from pulmonary metastases in less than twelve months. They occur in the limbs, but also frequently in the palate, the substance of the cheek, the mouth; they spread rapidly and destroy the surrounding tissues in an astonishing fashion. They appear to be entirely radioresistant. The common age of incidence is in the younger age-group, from 15 to 30 years, but they occur at any age and two of the 7 patients in this series were 50 and 65 years of age respectively.
(5) Angiosarcoma.-It is with some diffidence that I decided to include 10 patients under the heading of angiosarcoma. All 10 were reported on histologically as "angiosarcoma", "endothelial sarcoma", "malignant himangioendothelioma" or "very vascular round and spindle-cell sarcoma". They have this in common that they were tumours of soft tissue, 8 of them in the muscles and fascial planes of the limbs or back and 2 in the head and neck; 5 patients died of metastasis and 5 are alive for long periods, twenty-one, eighteen, fifteen, fourteen and eight years respectively. It is difficult to decide which of the numerous names applied by different pathologists really represents the nature of the tumour.
It is difficult also to form a definite opinion as to the histogenesis of this group of tumours and the term "angiosarcoma" is used here in a descriptive and not histogenetic sense. All tumours were markedly vascular, some entirely composed of thin-walled cysts filled with blood, lined by a scanty layer of fusiform cells. In 2 patients these cystlike trabeculated tumours had their origin within a muscle and replaced a portion of it. In others the tumour could be described as an extremely vascular spindle-cell sarcoma spreading in the cellular intermuscular planes. Whatever their nature, they seem, at least on gross macroscopic appearance, to fall into a group different from the 4 other types. As to their malignant nature there is, of course, no doubt in the 5 patients who died from metastases: a boy, 19 years of age with a tumour in the calf of the leg, died of pulmonary metastases after amputation; a child 3 years of age with a tumour in her thigh, died within six months and a girl 19 years of age with a tumour in the forearm died with pulmonary metastasis within three years from the onset of the disease; 2 other cases died of widespread disease. Of the 5 patients who have survived for very prolonged periods, one had five local recurrences following local excision before a much wider excision and post-operative radiation controlled the disease. An analysis of the result of treatment is shown in Tables IX, X, XI, XII.  Table IX shows that the prognosis is much better when the tumour is situated in the limbs or trunk than when it arises in the face, mouth, retroperitoneal tissues or when it is multiple in origin. Table X shows that long periods of survival up to twenty-six years have been obtained; most of the long survivals were actually in cases of fibrosarcoma. These periods of survival are counted from the onset of the disease and not from the last treatment in those cases where recurrence necessitated further treatment. Table XI is an analysis of the period of survival in the patients who died of the disease. It shows that 15 patients survived five to nine years and only 8 died within the first year; 2 patients survived twenty-two years. It indicates that even in the fatal cases the progress of the disease is slow in most patients. It was, I thought, of interest to try and correlate the method of treatment with the results obtained. Three main methods were used: (1) Wide excision in association with radiotherapy, both pre-and post-operative; (2) amputation, alone or with radiation; (3) radiation only. Table XIII shows the results obtained in 128 cases. It is, of course, obvious that those submitted to amputation were more advanced, or more malignant than those where wide local excision appeared to offer a reasonable chance. Similarly when radiation alone was used, the tumour was either irremovable or there was some other cause why more classical methods of treatment were not adopted. The cases are therefore not strictly comparable and the Table is chiefly of interest in showing the following points: (1) Where wide local excision with radiation was used more patients survived than died; (2) when amputation was carried out, more patients died of their disease than survived; (3) when radiation alone was used 6 patients got rid oftheir tumour completely, and for very long periods, although 16 did not and died of the disease.
RESULTS OF TREATMENT
In the light of experience further points were noted and these can be summarized as follows: (1) Whenever local excision by enucleation of the tumour was used, the result was a failure, the tumour recurred and with such repeated local excisions kept on recurring. I am sure that there are many surgeons who have had this experience.
(2) The knowledge of the histological type is of practical importance, as of the five groups, the rarer types consisting of highly specialized cells are the most malignant; and the commonest variety, the fibrosarcoma, offers a more hopeful outlook.
(3) Amputation does by no means result in a "cure" and, as a matter of fact, more patients died of their disease when this method was used than when wide local excision was practised. The indications for amputation are limited; it should be used when a limb is otherwise uneconomical and a burden; when the tumour by its size or site does not lend itself to local excision; when the histological type is such that more conservative measures have proved unsuccessful, for instance rhabdomyosarcoma and liposarcoma.
(4) Neither should radiation alone be advised as the method of choice in cases suitable for wide excision. We have not yet reached the stage when radiation can be offered to the patient as equally effective if the tumour can in fact be removed. It is important that the patient should not become a radiotherapeutic guinea-pig, neither should he be a victim of ablational enthusiasm and of surgical heroics.
Radiation as the sole method of treatment is advocated only in a selected group of cases, where surgery is not applicable. 22 patients received radiation only, of these 16 died. The 6 survivals, however, are worth mentioning. In one case, a malignant tumour of the pectoral group of muscles-proved histologically a fibrosarcoma-was treated by radium over a period of three years; she is alive to-day twenty-six years later. Two other patients with tumours in Scarpa's triangle, of similar histology, survived radiotherapy to date, seventeen and fifteen years respectively. One infant 14 weeks old with a tumour in the sternomastoid and invasion of the clavicle with osteolysis of the inner third of the bone, treated by radium survives to date, eighteen years. A case of soft tissue tumour in the region of the head of the fibula treated by radiation only is alive to-day, five years later, and a tumour in the scalene musclesreported variously as neurogenic sarcoma and fibrosarcoma-irremovable, although explored twice, has regressed following radiotherapy, now in the fifth year after treatment. These cases show clearly that "radioresistance" does not signify that radiotherapy should not be used and that many years of survival can be achieved by radiation alone. Radiation is of considerable value and plays an important part in the treatment and has given results when used in combination with surgery, better than surgery alone, however extensive the surgery. But sarcoma of soft tissue, like bone sarcoma is classed as a "radioresistant" tumour, that is, it requires more radiation to obtain regression as compared to some other tumours. It is in view of this acknowledged "radioresistance" of soft tissue sarcoma, that the meaning of the term "radioresistant" should be reviewed; chiefly it should not be considered as a contra-indication for radiotherapy. This becomes of greater importance with the development of more powerful sources of radiation, more accurate treatment and a better understanding of the mode of action of radiation. It is my experience that fibrosarcoma, like osteogenic sarcoma, if it is to benefit from radiotherapy should be given less and not more radiation and that the time factor must be greatly prolonged. The actual technique of treatment is quite different from that used in the treatment of the common epithelial tumours and the highly radiosensitive neoplasms. I think it is not fortuitous that in this series, survival up to twenty-six years has been obtained and that half the patients have been salvaged. I believe it is due not so much to my enthusiasm as to the biological effects of ionizing energy and to the adjustment of the surgical act, in its extent and the timing of its performance, to the natural history of the tumour and its alteration by pre-operative treatment. It cannot be denied that the results in this series, the largest yet recorded from a single source, are better numerically and in prolongation of the periods with freedom of disease than when surgery alone is used. I have asked myself and I have been asked by many others why delay in surgical treatment, and why pre-operative radiation should affect the issue? There is no certain explanation for this although we have been seeking it for many years. In fact why should the group of cases where this combined and prolonged treatment was carried out, show a smaller incidence of metastases? I venture to offer the following explanation. In epithelial tumours of small volume, for instance cancer of the tongue, a very high total dose of 6,000 r to 10,000 r leads to death of the cancer cells and resorption of the tumour. Such a method is not applicable to large volume tumours, neither is it applicable to the so-called "radioresistant" neoplasms. But penetrating radiation at a lower total dose and especially at a slower dose rate, affects the tissues in other ways or to a different degree. One way of mastering a cancer cell besides killing it outright, is to alter its reproductive rate or power. It is well known that chromosomal breaks result from radiation and of course from other causes such as chemical action, e.g. nitrogen mustard. A chromosomal break if complete and if affecting all cells would result in cancer becoming a self-limiting process. But the breaks in the chromosomes at low dosage levels do heal and this leads to an increase in the number of mutations; this in turn reduces the power of cell division in the daughter cells derived from these and so after a generation or two or more, the end-result is sterility of the cell. Such sterile cells, capable of survival but incapable of reproduction, when disseminated by embolism to the lung or other organs cannot form metastases. Such pulmonary emboli are known to occur during pregnancy when cells of chorionic type are found in the lungs of pregnant womenand yet never form metastases of chorionepithelioma, and disappear spontaneously. If such a process is normal in physiological phenomena, it is possible for it to occur in pathological processes if the cell carried by embolism is actually incapable of reproducing itself. Such an explanation, that gene mutation follows the chromosome break resulting from radiation, is accepted by geneticists. Some geneticists consider that-an increased rate of gene mutation, beyond what is needed for the evolution of a species by natural selection, is "wholly bad". Bad for the individual, for the offspring and indeed for the species. If such mutation is wholly bad for normal growth-it is indeed nothing but wholly good in the control of growth of cancer-cells. But although an alteration in the nuclear structure of the cells seems a possible explanation, it may not be the correct one. Sublethal radiation may also affect the molecular structure of cells and lead to chemical changes permitting survival of cells but resulting in their sterility. This may explain the beneficial effects of protracted treatment amounting in all to moderate tissue doses. Such treatment is compatible with subsequent surgical excision of the tumour. A wide local excision, including a wide margin of healthy tissue, excision of a complete muscle or muscle group preceded and followed by radiation seems to be the method of choice. An analysis of the patients who died from the disease, shows a substantially longer survival after excision and radiation than after amputation. Thus of the 16 patients submitted to amputation who subsequently died of the disease, only 1 survived nine years, 1 six years, 3 four years, 6 two to three years and 5 less than two years. Whereas of the 31 patients who died of their disease after excision and radiation, 1 each lived thirteen, twelve, ten and nine years, 2 for six years, 8 for five years, 9 for two to three years and 8 for one year or less. I do not know if these figures are statistically significant, but more patients lived for considerable periods, five to thirteen years, with the combination of conservative surgery and radiation, than with amputation.
It seems essential before deciding on a plan of treatment to have an accurate knowledge of the tumour and this can only be achieved by a biopsy, providing ample material for the pathologist.
In conclusion the study of this series of soft tissue sarcoma shows that just over half the patients with tumours in the limbs survived for prolonged periods; that most patients with tumours in odd sites died. That decision as to method of treatment depends on the histology and the site of the tumour. That amputation was indicated in less than a quarter of the total number; that in the common histological type, fibrosarcoma, the disease is of slow evolution and survival periods of many years can be obtained. Perhaps this justifies a more optimistic view than is generally held.
It has also emerged from the study of these tumours and observation of patients over long periods of time, that there is a fundamental difference between the behaviour of sarcoma both of soft tissue and osteogenic and that of epithelial malignant growths. In the case of cancer of epithelial origin, delay in treatment is detrimental and loses the patient his best chance; not so in sarcoma, here the best end-results are actually seen in the patients in whom for some reason or other there was some delay before surgery was undertaken. If this period of waiting before excising the tumour or amputating the limb is used in radiotherapy, such delay becomes of benefit in a positive sense. It is also of interest to note that several female patients with soft tissue sarcoma in whom arrest of the disease was obtained, subsequently experienced one or more normal pregnancies without recrudescence of tumour activity or recurrence.
Finally I would like to thank those who rendered this study possible, especially Miss P. Wheatley whose care of the notes and follow-up provided a completeness of records which could hardly be surpassed. Dr. G. D. Lumb and Dr. M. Bodian for a review of many histological sections, some over twenty years old, and for their opinion as to the type of tumour. I am indebted to Dr. P. Hansell for the photography of the material. To my clinical colleagues at Westminster Hospital and elsewhere, I owe a debt of gratitude for access to some of the patients in this series and to my friend and colleague Dr. F. M. Allchin for many years of collaboration in the treatment of these patients, especially by radiotherapy. And so to conclude on an optimistic note: Sarcoma of soft tissue in spite of its evil reputation, if treated adequately offers on the whole, a 50% chance of prolonged survival-which is indeed better than in most other groups of cancer.
